BIIB141 (Omaveloxolone)
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for BIIB141 (Omaveloxolone), covering 2025-04-10 to 2026-03-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn More About the Effects and Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old (BRAVE) [Phase 3]